Nanomaterial based Magnetic Resonance Imaging of Cancer
暂无分享,去创建一个
Asampille Gitanjali | Varsha Brahmkhatri | Hanudatta S. Atreya | H. Atreya | V. Brahmkhatri | A. Gitanjali
[1] Wenbin Lin,et al. Surfactant-assisted synthesis of nanoscale gadolinium metal-organic frameworks for potential multimodal imaging. , 2008, Angewandte Chemie.
[2] Yongmin Chang,et al. Paramagnetic nanoparticle T1 and T2 MRI contrast agents. , 2012, Physical chemistry chemical physics : PCCP.
[3] A. Djamali,et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. , 2007, Radiology.
[4] L. De Cola,et al. Alkyl-functionalized oxide-free silicon nanoparticles: synthesis and optical properties. , 2008, Small.
[5] H. Chung,et al. Nanomaterials for cancer therapy and imaging , 2011, Molecules and cells.
[6] D. Brenner,et al. Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.
[7] S. Hussain,et al. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging , 2001, European Radiology.
[8] Xiaoyuan Chen,et al. Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. , 2009, Biomaterials.
[9] K Kostarelos,et al. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. , 2009, Nature nanotechnology.
[10] A. R. Ramjaun,et al. The role of cell adhesion pathways in angiogenesis. , 2009, The international journal of biochemistry & cell biology.
[11] H. Bengele,et al. A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. , 1990, Magnetic resonance imaging.
[12] A. P. Hall. The role of angiogenesis in cancer , 2005, Comparative Clinical Pathology.
[13] Sophie Lanone,et al. Potential uses of carbon nanotubes in the medical field: how worried should patients be? , 2007, Nanomedicine.
[14] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[15] M. Allendorf,et al. Metal‐Organic Frameworks: A Rapidly Growing Class of Versatile Nanoporous Materials , 2011, Advanced materials.
[16] É. Boisselier,et al. Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine. , 2010, Chemical reviews.
[17] Wolfgang J Parak,et al. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. , 2010, Pharmacological research.
[18] P. Huang,et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.
[19] Peter Wipf,et al. Nanoparticles in cellular drug delivery. , 2009, Bioorganic & medicinal chemistry.
[20] Samuel A. Wickline,et al. Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .
[21] C. Gladson. Expression of Integrin avß3 in Small Blood Vessels of Glioblastoma Tumors , 1996 .
[22] Cecilia Sahlgren,et al. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges. , 2010, Nanoscale.
[23] Juan Zhao,et al. Platelet Factor 4 Inhibits IL-17/Stat3 Pathway via Upregulation of SOCS3 Expression in Melanoma , 2014, Inflammation.
[24] Zhen Guo,et al. Multifunctional Fe3O4@C@Ag hybrid nanoparticles as dual modal imaging probes and near-infrared light-responsive drug delivery platform. , 2013, Biomaterials.
[25] Kevin Brindle,et al. New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.
[26] Junichi Takagi,et al. Global Conformational Rearrangements in Integrin Extracellular Domains in Outside-In and Inside-Out Signaling , 2002, Cell.
[27] M. Maio,et al. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels , 2003, Oncogene.
[28] P. Gimotty,et al. Novel surface targets and serum biomarkers from the ovarian cancer vasculature , 2011, Cancer biology & therapy.
[29] MRI‐Visual Order–Disorder Micellar Nanostructures for Smart Cancer Theranostics , 2014, Advanced healthcare materials.
[30] F. Vögtle,et al. Dendrimers and Dendrons: Concepts, Syntheses, Applications , 2001 .
[31] William C. Zamboni,et al. Concept and clinical evaluation of carrier-mediated anticancer agents. , 2008, The oncologist.
[32] David A. Cheresh,et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins , 1995, Science.
[33] Sungho Jin,et al. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. , 2007, Biomaterials.
[34] Yoon-Sik Lee,et al. Spontaneous formation of silver nanoparticles on polymeric supports , 2009 .
[35] M. Ciesielski,et al. Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent. , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[36] N. M. Rao,et al. Haloperidol-associated Stealth Liposomes , 2005, Journal of Biological Chemistry.
[37] David A. Cheresh,et al. Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.
[38] Jinyoung Hwang,et al. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t1- and T2-weighted magnetic resonance imaging. , 2010, Bioconjugate chemistry.
[39] Yang Sun,et al. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells. , 2012, Biomaterials.
[40] Benjamin R. Jarrett,et al. Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging. , 2008, Bioconjugate chemistry.
[41] Jun Gao,et al. PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging. , 2013, Biomaterials.
[42] Richard O Hynes,et al. Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.
[43] K. Geboes,et al. The Angiogenic Biomarker Endocan is Upregulated in Proliferative Diabetic Retinopathy and Correlates with Vascular Endothelial Growth Factor , 2015, Current eye research.
[44] Chunhua Yan,et al. Luminescent rare earth nanomaterials for bioprobe applications. , 2008, Dalton transactions.
[45] R. Palmer,et al. Cytotoxicity of the rare earth metals cerium, lanthanum, and neodymium in vitro: comparisons with cadmium in a pulmonary macrophage primary culture system. , 1987, Environmental research.
[46] D. Gingras,et al. VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases. , 2007, Thrombosis research.
[47] Gérard Férey,et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. , 2010, Nature materials.
[48] Zhen Cheng,et al. Ultrasmall near-infrared non-cadmium quantum dots for in vivo tumor imaging. , 2010, Small.
[49] P. Wick,et al. Carbon nanotubes - curse or blessing. , 2011, Current medicinal chemistry.
[50] Angelique Y. Louie,et al. Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging. , 2007 .
[51] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[52] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[53] M. Yeh,et al. Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery , 2013, International journal of nanomedicine.
[54] Angelique Louie,et al. Multimodality imaging probes: design and challenges. , 2010, Chemical reviews.
[55] Wenbin Lin,et al. Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. , 2008, Journal of the American Chemical Society.
[56] Sudesh Kumar Yadav,et al. Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.
[57] T. Rhim,et al. Recombinant human prothrombin kringles have potent anti-angiogenic activities and inhibit Lewis lung carcinoma tumor growth and metastases , 2004, Angiogenesis.
[58] J. Muller. Potential inhibition of the neuro-neoplastic interactions: the clue of a GPCR-targeted therapy. , 2007, Progress in experimental tumor research.
[59] U. Cavallaro,et al. The functional role of cell adhesion molecules in tumor angiogenesis. , 2009, Seminars in cancer biology.
[60] Kai Chen,et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. , 2010, Biomaterials.
[61] R. Schiffelers,et al. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[62] Eric C. Carnes,et al. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. , 2013, Accounts of chemical research.
[63] L. Zhang,et al. Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.
[64] P. Kolattukudy,et al. Monocyte Chemotactic Protein (MCP)-1 Promotes Angiogenesis via a Novel Transcription Factor, MCP-1-induced Protein (MCPIP)* , 2008, Journal of Biological Chemistry.
[65] Qiang Wang,et al. Polyhydroxy fullerenes for non-invasive cancer imaging and therapy. , 2010, Small.
[66] Priyabrata Mukherjee,et al. Biological properties of "naked" metal nanoparticles. , 2008, Advanced drug delivery reviews.
[67] H. Maeda,et al. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[68] M. Poettler,et al. Tumorangiogenese – Grundlagen und Therapieansätze , 2012 .
[69] Weibo Cai,et al. Imaging of integrins as biomarkers for tumor angiogenesis. , 2008, Current pharmaceutical design.
[70] Yuliang Zhao,et al. Engineered design of theranostic upconversion nanoparticles for tri-modal upconversion luminescence/magnetic resonance/X-ray computed tomography imaging and targeted delivery of combined anticancer drugs. , 2014, Journal of materials chemistry. B.
[71] M. Dobrovolskaia,et al. Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.
[72] R. Weissleder,et al. Imaging in the era of molecular oncology , 2008, Nature.
[73] Xing-Jie Liang,et al. Theranostic nanoparticles engineered for clinic and pharmaceutics. , 2011, Accounts of chemical research.
[74] Xiaohu Gao,et al. Multifunctional Quantum Dots for Personalized Medicine. , 2009, Nano today.
[75] T. Yin,et al. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy. , 2013, Pharmacological research.
[76] Hong Yang,et al. Solvothermal synthesis of cobalt ferrite nanoparticles loaded on multiwalled carbon nanotubes for magnetic resonance imaging and drug delivery. , 2011, Acta biomaterialia.
[77] Dong Wook Kim,et al. Prostate Cancer-Targeted Imaging Using Magnetofluorescent Polymeric Nanoparticles Functionalized with Bombesin , 2010, Pharmaceutical Research.
[78] Christopher H Contag,et al. In vivo pathology: seeing with molecular specificity and cellular resolution in the living body. , 2007, Annual Review of Pathology.
[79] Thomas Beyer,et al. PET/CT scanners: a hardware approach to image fusion. , 2003, Seminars in nuclear medicine.
[80] A. Wanekaya,et al. Functionalized gold nanoparticles for the binding, stabilization, and delivery of therapeutic DNA, RNA, and other biological macromolecules. , 2010, Nanotechnology, science and applications.
[81] C. Mou,et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. , 2010, Angewandte Chemie.
[82] P. Carmeliet. Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.
[83] R. Weissleder. Molecular Imaging in Cancer , 2006, Science.
[84] S. Sahoo,et al. Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.
[85] M. Dewhirst,et al. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery , 2004, Magnetic resonance in medicine.
[86] Xiaoyuan Chen,et al. 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[87] J. Bulte,et al. Magnetic resonance imaging of cell surface receptors using targeted contrast agents. , 2004, Current pharmaceutical biotechnology.
[88] Shuang Liu. Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3 Targeted Radiotracers for Tumor Imaging , 2006 .
[89] Ki Young Choi,et al. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. , 2012, Nanoscale.
[90] S. Caruthers,et al. Three‐dimensional MR mapping of angiogenesis with α5β1(αvβ3)‐targeted theranostic nanoparticles in the MDA‐MB‐435 xenograft mouse model , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[91] L. Claesson‐Welsh,et al. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. , 2001, Trends in pharmacological sciences.
[92] Leone Spiccia,et al. Nanomaterials: Applications in Cancer Imaging and Therapy , 2011, Advanced materials.
[93] J. Kos,et al. Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours , 2005, Expert opinion on biological therapy.
[94] J. Folkman,et al. Anti‐Angiogenesis: New Concept for Therapy of Solid Tumors , 1972, Annals of surgery.
[95] Bart Landuyt,et al. Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.
[96] J. Rhim,et al. Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins , 2004, The Journal of cell biology.
[97] P. Ang,et al. Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[98] Yihai Cao,et al. PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells , 2011, Nature Medicine.
[99] E Ruoslahti,et al. New perspectives in cell adhesion: RGD and integrins. , 1987, Science.
[100] J. Rundhaug,et al. Matrix metalloproteinases and angiogenesis , 2005, Journal of cellular and molecular medicine.
[101] Tamitake Itoh,et al. Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications , 2008, Analytical and bioanalytical chemistry.
[102] A. Bikfalvi,et al. Target molecules for anti-angiogenic therapy: from basic research to clinical trials. , 2000, Critical reviews in oncology/hematology.
[103] A. Blamire,et al. The technology of MRI--the next 10 years? , 2008, The British journal of radiology.
[104] J. Brugge,et al. Src kinase activation by direct interaction with the integrin β cytoplasmic domain , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[105] Mrinmoy De,et al. Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications. , 2011, Advanced drug delivery reviews.
[106] Joop A. Peters,et al. Gadolinium(III)-loaded nanoparticulate zeolites as potential high-field MRI contrast agents: relationship between structure and relaxivity. , 2005, Chemistry.
[107] Yeup Yoon,et al. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site , 2011, Biological chemistry.
[108] Sang Moo Lim,et al. RGD Peptide–Conjugated Multimodal NaGdF4:Yb3+/Er3+ Nanophosphors for Upconversion Luminescence, MR, and PET Imaging of Tumor Angiogenesis , 2013, The Journal of Nuclear Medicine.
[109] Jerry S. H. Lee,et al. Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.
[110] V. Morris,et al. Differences in phosphatase modulation of α4 β1 and α5 β1 integrin-mediated adhesion and migration of B16F1 cells , 1999 .
[111] M. Greenblatt,et al. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. , 1968, Journal of the National Cancer Institute.
[112] M. Prato,et al. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. , 2006, Advanced drug delivery reviews.
[113] Akiyoshi Hoshino,et al. Water-soluble photoluminescent silicon quantum dots. , 2005, Angewandte Chemie.
[114] Naomi J Halas,et al. Theranostic nanoshells: from probe design to imaging and treatment of cancer. , 2011, Accounts of chemical research.
[115] Tingxian Liu,et al. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer. , 2014, Nanoscale.
[116] Jodie L. Conyers,et al. Biomedical applications of functionalized fullerene-based nanomaterials , 2009, International journal of nanomedicine.
[117] S. Banerjee,et al. Multifunctional pH-sensitive magnetic nanoparticles for simultaneous imaging, sensing and targeted intracellular anticancer drug delivery , 2008, Nanotechnology.
[118] Shuming Nie,et al. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery , 2006, Molecular Cancer Therapeutics.
[119] A. Kakkar,et al. Advances in the elegance of chemistry in designing dendrimers. , 2010, Macromolecular rapid communications.
[120] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[121] I. Charles,et al. Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[122] Yun Sun,et al. Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging. , 2013, ACS nano.
[123] Younan Xia,et al. Gold nanostructures: a class of multifunctional materials for biomedical applications. , 2011, Chemical Society reviews.
[124] Andrew Bulpitt. Fundamentals of MRI: An Interactive Learning Approach , 2008 .
[125] Weibo Cai,et al. Multimodality Molecular Imaging of Tumor Angiogenesis , 2008, Journal of Nuclear Medicine.
[126] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[127] T. Irimura,et al. Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer , 2004, Clinical Cancer Research.
[128] R. Xavier,et al. Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.
[129] Rick M Dijkhuizen,et al. Tumor angiogenesis phenotyping by nanoparticle-facilitated magnetic resonance and near-infrared fluorescence molecular imaging. , 2012, Neoplasia.
[130] A. Klibanov,et al. Drastically lowered protein adsorption on microbicidal hydrophobic/hydrophilic polyelectrolyte multilayers. , 2012, Biomacromolecules.
[131] B. Garmy-Susini,et al. Roles of integrins in tumor angiogenesis and lymphangiogenesis. , 2008, Lymphatic research and biology.
[132] Fiona Murphy,et al. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. , 2011, Nanomedicine.
[133] A. Ivanisevic,et al. Examining MRI contrast in three-dimensional cell culture phantoms with DNA-templated nanoparticle chains. , 2011, ACS applied materials & interfaces.
[134] George M Whitesides,et al. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors. , 1998, Angewandte Chemie.
[135] K. Wu,et al. Evaluation of the antibacterial efficacy of bamboo charcoal/silver biological protective material , 2009 .
[136] E Ruoslahti,et al. RGD and other recognition sequences for integrins. , 1996, Annual review of cell and developmental biology.
[137] M. Prato,et al. Chemistry of carbon nanotubes. , 2006, Chemical reviews.
[138] M. Brechbiel,et al. Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiography. , 2012, Molecular pharmaceutics.
[139] Kwangmeyung Kim,et al. Engineered protein nanoparticles for in vivo tumor detection. , 2014, Biomaterials.
[140] M. D. Rowe,et al. Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer. , 2009, Biomacromolecules.
[141] Sungho Jin,et al. Magnetic nanoparticles for theragnostics. , 2009, Advanced drug delivery reviews.
[142] J. Lilien,et al. Impaired Integrin-mediated Adhesion and Signaling in Fibroblasts Expressing a Dominant-negative Mutant PTP1B , 1998, The Journal of cell biology.
[143] M. Prato,et al. Functionalized carbon nanotubes in drug design and discovery. , 2008, Accounts of chemical research.
[144] P. Heegaard,et al. Dendrimers in drug research. , 2004, Chemical Society reviews.
[145] Kelly Y. Kim,et al. Nanotechnology platforms and physiological challenges for cancer therapeutics , 2007 .
[146] S. Gambhir,et al. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.
[147] S. Nie,et al. In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.
[148] Enzo Terreno,et al. Challenges for molecular magnetic resonance imaging. , 2010, Chemical reviews.
[149] E. Frenkel,et al. Nanoparticles for drug delivery in cancer treatment. , 2008, Urologic oncology.
[150] Taeghwan Hyeon,et al. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. , 2011, Accounts of chemical research.
[151] L. Patterson,et al. Function and antagonism of beta3 integrins in the development of cancer therapy. , 2009, Current cancer drug targets.
[152] Arthur G Erdman,et al. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. , 2013, Nanomedicine : nanotechnology, biology, and medicine.
[153] M. Klein,et al. Virgil Percec and Other Complex Architectures Self-Assembly of Janus Dendrimers into Uniform Dendrimersomes , 2014 .
[154] Martin W. Brechbiel,et al. Dendrimer-based macromolecular MRI contrast agents: characteristics and application. , 2003 .
[155] R. Haag,et al. Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. , 2002, Angewandte Chemie.
[156] J. Pollard,et al. NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. , 2013, Blood.
[157] P. Choyke,et al. Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics. , 2012, Bioconjugate chemistry.
[158] Yun Chi,et al. Iridium-complex-functionalized Fe3O4/SiO2 core/shell nanoparticles: a facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy. , 2008, Small.
[159] Ralph Weissleder,et al. Sensitive, Noninvasive Detection of Lymph Node Metastases , 2004, PLoS medicine.
[160] L. True,et al. Quantum dots for molecular pathology: their time has arrived. , 2007, The Journal of molecular diagnostics : JMD.
[161] Yan Xing,et al. Radiolabeled Nanoparticles for Multimodality Tumor Imaging , 2014, Theranostics.
[162] C. Sorenson,et al. PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions. , 2010, American journal of physiology. Cell physiology.
[163] Stephanie Alexander,et al. Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.
[164] Lanthanide Loaded Zeolites, Clays, and Mesoporous Silica Materials as MRI Probes , 2012 .
[165] M. D. Rowe,et al. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[166] P. Pantazis,et al. Paramagnetic, silicon quantum dots for magnetic resonance and two-photon imaging of macrophages. , 2010, Journal of the American Chemical Society.
[167] M. Ballauff,et al. Dendrimers in solution: insight from theory and simulation. , 2004, Angewandte Chemie.
[168] D. Cheresh,et al. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. , 1995, Journal of cell science.
[169] G. Tucker. Integrins: Molecular targets in cancer therapy , 2006, Current oncology reports.
[170] Scott H. Medina,et al. Dendrimers as carriers for delivery of chemotherapeutic agents. , 2009, Chemical reviews.
[171] M. Iruela-Arispe,et al. ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165* , 2003, Journal of Biological Chemistry.
[172] J. Minna,et al. MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. , 2010, Molecular pharmaceutics.
[173] E. Rozhkova,et al. Nanoscale Materials for Tackling Brain Cancer: Recent Progress and Outlook , 2011, Advanced materials.
[174] W. Parak,et al. Polymeric‐Gold Nanohybrids for Combined Imaging and Cancer Therapy , 2014, Advanced healthcare materials.
[175] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[176] David A. Benaron,et al. The Future of Cancer Imaging , 2004, Cancer and Metastasis Reviews.
[177] P. Alivisatos. The use of nanocrystals in biological detection , 2004, Nature Biotechnology.
[178] Harish Poptani,et al. MR techniques for in vivo molecular and cellular imaging. , 2005, Radiologic clinics of North America.
[179] Hua Ai,et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. , 2006, Nano letters.
[180] Z. Popović,et al. Amine-terminated silicon nanoparticles: synthesis, optical properties and their use in bioimaging , 2009 .
[181] A. Paradiso,et al. Tumor endothelial markers as a target in cancer , 2012, Expert opinion on therapeutic targets.
[182] L. Schwartz,et al. Imaging approaches with advanced prostate cancer: techniques and timing. , 2014, The Canadian journal of urology.
[183] Maureen A Walling,et al. Quantum Dots for Live Cell and In Vivo Imaging , 2009, International journal of molecular sciences.
[184] R. Assoian,et al. Regulation of growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension. , 2005, Cytokine & growth factor reviews.
[185] Chungho Kim,et al. The final steps of integrin activation: the end game , 2010, Nature Reviews Molecular Cell Biology.
[186] Luisa De Cola,et al. Photoactive hybrid nanomaterial for targeting, labeling, and killing antibiotic-resistant bacteria. , 2009, Angewandte Chemie.
[187] Efficient pro-survival/angiogenic miRNA delivery by an MRI-detectable nanomaterial. , 2013, ACS nano.
[188] Julia Xiaojun Zhao,et al. Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[189] Z. Fayad,et al. Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots , 2008, Angiogenesis.
[190] Vincent M. Rotello,et al. Multimodal drug delivery using gold nanoparticles. , 2009, Nanoscale.
[191] H. Bi,et al. The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1 , 2014, Molecular vision.
[192] Ralph Weissleder,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.
[193] Donghoon Lee,et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.
[194] Karolin F Meyer,et al. Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications. , 2008, Bioconjugate chemistry.
[195] Vincent M Rotello,et al. Photoregulated release of caged anticancer drugs from gold nanoparticles. , 2009, Journal of the American Chemical Society.
[196] W. Zamboni. Liposomal, Nanoparticle, and Conjugated Formulations of Anticancer Agents , 2005, Clinical Cancer Research.
[197] P. Gullino,et al. Angiogenesis and oncogenesis. , 1978, Journal of the National Cancer Institute.
[198] J. Calvete. Structure-function correlations of snake venom disintegrins. , 2005, Current pharmaceutical design.
[199] K. Yong. Mn-doped near-infrared quantum dots as multimodal targeted probes for pancreatic cancer imaging , 2009, Nanotechnology.
[200] M. Knoth,et al. Choriocarcinoma. Transfilter stimulation of vasoproliferation in the hamster cheek pouch. Studied by light and electron microscopy. , 1968, Journal of the National Cancer Institute.
[201] Osamu Togao,et al. Investigation of In Vivo Targeting Kinetics of αvβ3-Specific Superparamagnetic Nanoprobes by Time-Resolved MRI , 2011, Theranostics.
[202] Jeffery A. Jones,et al. Multisensory and modality specific processing of visual speech in different regions of the premotor cortex , 2014, Front. Psychol..
[203] J. Mathews,et al. Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians , 2013, BMJ.
[204] F. Grizzi,et al. Is angiogenesis a hallmark of prostate cancer? , 2013, Front. Oncol..
[205] A. Eggermont,et al. TNF-based isolated limb perfusion: a decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas. , 2004, Cancer treatment and research.
[206] P. Ajayan,et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation , 2009, Proceedings of the National Academy of Sciences.
[207] S. Nie,et al. Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .
[208] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[209] C. Anderson,et al. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). , 2009, Accounts of chemical research.
[210] K. Jain. The role of nanobiotechnology in drug discovery. , 2009, Advances in experimental medicine and biology.
[211] H. Atreya,et al. Spontaneous and reversible self-assembly of a polypeptide fragment of insulin-like growth factor binding protein-2 into fluorescent nanotubular structures. , 2010, Chemical communications.
[212] E. Goldmann. The Growth of Malignant Disease in Man and the Lower Animals, with special reference to the Vascular System. , 1907, Proceedings of the Royal Society of Medicine.
[213] M. Reza Mozafari,et al. Nanomaterials and nanosystems for biomedical applications , 2007 .
[214] Sharon Bloch,et al. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. , 2006, Journal of medicinal chemistry.
[215] U. Mueller,et al. Metal–organic frameworks—prospective industrial applications , 2006 .
[216] F. Auzel. Upconversion and anti-Stokes processes with f and d ions in solids. , 2004, Chemical reviews.
[217] Scott C. Brown,et al. Nanoparticles for bioimaging. , 2006, Advances in colloid and interface science.
[218] K. Katahira,et al. Whole-body diffusion-weighted magnetic resonance imaging. , 2009, European journal of radiology.
[219] Saed Mirzadeh,et al. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo. , 2008, Nuclear medicine and biology.
[220] Hisataka Kobayashi,et al. Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals. , 2011, Chemical Society reviews.
[221] Yanqing Hua,et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. , 2012, Biomaterials.
[222] Jinming Gao,et al. In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles. , 2009, Cancer research.
[223] S. Gately,et al. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. , 2004, Seminars in oncology.
[224] Ling Wang,et al. Antiangiogenic Properties of Gold Nanoparticles , 2005, Clinical Cancer Research.
[225] Klaus Kopka,et al. Encapsulating (111)In in nanocontainers for scintigraphic imaging: synthesis, characterization, and in vivo biodistribution. , 2010, ACS nano.
[226] R Weissleder,et al. Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. , 2000, European journal of cancer.
[227] J. Kong,et al. Theranostics: MRI-Visualized, Dual-Targeting, Combined Tumor Therapy Using Magnetic Graphene-Based Mesoporous Silica (Small 1/2014) , 2014 .
[228] J. Bergelson,et al. Identification of the integrin VLA-2 as a receptor for echovirus 1. , 1992, Science.
[229] N. Logothetis. What we can do and what we cannot do with fMRI , 2008, Nature.
[230] Kyoungjune Pak,et al. Clinical Implication of PET/MR Imaging in Preoperative Esophageal Cancer Staging: Comparison with PET/CT, Endoscopic Ultrasonography, and CT , 2014, The Journal of Nuclear Medicine.
[231] H. W. Chalkley,et al. Vasculae Reactions of Normal and Malignant Tissues in Vivo. I. Vascular Reactions of Mice to Wounds and to Normal and Neoplastic Transplants , 1945 .
[232] Mark E. Davis,et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.
[233] Mizuo Maeda,et al. Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging. , 2009, Biochemical and biophysical research communications.
[234] C. ffrench-Constant,et al. Integrins: versatile integrators of extracellular signals. , 2004, Trends in cell biology.
[235] J. Willmann,et al. Molecular ultrasound assessment of tumor angiogenesis , 2010, Angiogenesis.
[236] Hyo‐suk Lee,et al. Tumor targeting by doxorubicin-RGD-4C peptide conjugate in an orthotopic mouse hepatoma model. , 2004, International journal of molecular medicine.
[237] H. Shan,et al. An RGD-Modified MRI-Visible Polymeric Vector for Targeted siRNA Delivery to Hepatocellular Carcinoma in Nude Mice , 2013, PloS one.
[238] C. Marcinkiewicz. Functional characteristic of snake venom disintegrins: potential therapeutic implication. , 2005, Current pharmaceutical design.
[239] J. Frangioni. In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.
[240] Henk-Jan Guchelaar,et al. Liposomal drug formulations in cancer therapy: 15 years along the road. , 2012, Drug discovery today.
[241] M. Stevens,et al. Engineering nanocomposite materials for cancer therapy. , 2010, Small.
[242] Hyung L. Kim. Optical imaging in oncology. , 2009, Urologic oncology.
[243] Yubao Li,et al. Preparation and antibacterial effect of silver–hydroxyapatite/titania nanocomposite thin film on titanium , 2008 .
[244] M. D. Rowe,et al. Synthesis of gadolinium nanoscale metal-organic framework with hydrotropes: manipulation of particle size and magnetic resonance imaging capability. , 2011, ACS applied materials & interfaces.
[245] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[246] O. Boerman,et al. Radionuclide imaging of tumor angiogenesis. , 2009, Cancer biotherapy & radiopharmaceuticals.
[247] Zhuo Georgia Chen,et al. Advances of cancer therapy by nanotechnology. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.